chr21-25689883-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_021219.4(JAM2):c.151A>C(p.Lys51Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_021219.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
JAM2 | NM_021219.4 | c.151A>C | p.Lys51Gln | missense_variant | 3/10 | ENST00000480456.6 | NP_067042.1 | |
JAM2 | NM_001270408.2 | c.151A>C | p.Lys51Gln | missense_variant | 3/10 | NP_001257337.1 | ||
JAM2 | NM_001270407.2 | c.134-3873A>C | intron_variant | NP_001257336.1 | ||||
JAM2 | NR_072999.2 | n.715A>C | non_coding_transcript_exon_variant | 3/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
JAM2 | ENST00000480456.6 | c.151A>C | p.Lys51Gln | missense_variant | 3/10 | 1 | NM_021219.4 | ENSP00000420419.1 | ||
JAM2 | ENST00000400532.5 | c.151A>C | p.Lys51Gln | missense_variant | 3/10 | 1 | ENSP00000383376.1 | |||
JAM2 | ENST00000312957.9 | c.134-3873A>C | intron_variant | 2 | ENSP00000318416.6 | |||||
JAM2 | ENST00000460679.5 | n.16A>C | non_coding_transcript_exon_variant | 1/9 | 3 | ENSP00000436801.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 08, 2024 | The c.151A>C (p.K51Q) alteration is located in exon 3 (coding exon 3) of the JAM2 gene. This alteration results from a A to C substitution at nucleotide position 151, causing the lysine (K) at amino acid position 51 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.